跳至主要内容
临床试验/IRCT20200409047007N3
IRCT20200409047007N3招募中3 期

The effect of concurrent administration of melatonin and neoadjuvant Chemotherapy on the pathological response in breast cancer patients

Mashhad University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
Female

入选标准

  • Patients with stage one to three breast cancers
  • Age 30 to 60 years at the time of starting chemotherapy

排除标准

  • No previous history of chemotherapy
  • Absence of contraindications to neoadjuvant chemotherapy for breast cancer including heart failure and drug sensitivity
  • Absence of uncontrolled diabetes, renal failure with glomerular filtration less than 30 and liver failure

研究者

相似试验